We develop a
mathematical model that explicitly represents many of the known
signaling components mediating translocation of the insulin-responsive
glucose transporter GLUT4 to gain insight into the complexities of
metabolic insulin signaling pathways. A novel mechanistic model of
postreceptor events including phosphorylation of insulin receptor
substrate-1, activation of phosphatidylinositol 3-kinase, and
subsequent activation of downstream kinases Akt and protein kinase
C-
is coupled with previously validated subsystem models of insulin
receptor binding, receptor recycling, and GLUT4 translocation. A system
of differential equations is defined by the structure of the model.
Rate constants and model parameters are constrained by published
experimental data. Model simulations of insulin dose-response
experiments agree with published experimental data and also generate
expected qualitative behaviors such as sequential signal amplification
and increased sensitivity of downstream components. We examined the
consequences of incorporating feedback pathways as well as representing
pathological conditions, such as increased levels of protein tyrosine
phosphatases, to illustrate the utility of our model for exploring
molecular mechanisms. We conclude that mathematical modeling of signal
transduction pathways is a useful approach for gaining insight into the
complexities of metabolic insulin signaling.
 |
INTRODUCTION |
INSULIN IS AN
ESSENTIAL peptide hormone discovered in 1921 that regulates
metabolism (26). Interestingly, the ability of insulin to
promote glucose uptake into tissues was not demonstrated until 1949 (27). In 1971, specific cell surface insulin receptors were identified (12). The discovery that
insulin-stimulated glucose transport involves translocation of glucose
transporters (e.g., GLUT4) from an intracellular compartment to the
cell surface was made in 1980 (8, 53). Since genes
encoding the human insulin receptor and GLUT4 were cloned in 1985 (10, 54) and 1989 (5, 13), respectively,
steady progress has been made in identifying components of insulin
signal transduction pathways leading from the insulin receptor to
translocation of GLUT4 (see Ref. 32 for review).
On binding insulin, the insulin receptor undergoes receptor
autophosphorylation and enhanced tyrosine kinase activity.
Subsequently, intracellular substrates (e.g., insulin receptor
substrate-1, IRS-1) are phosphorylated on tyrosine residues that serve
as docking sites for downstream SH2 domain containing proteins,
including the p85 regulatory subunit of phosphatidylinositide
3-kinase (PI 3-kinase). The p85 binding to phosphorylated IRS-1
results in activation of the p110 catalytic subunit of PI 3-kinase
that catalyzes production of phosphoinositol lipids including
phosphatidylinositol 3,4,5-trisphosphates [PI(3,4,5)P3]
that activate the Ser/Thr kinase 3-phosphoinositide-dependent protein
kinase (PDK)-1. PDK-1 phosphorylates and activates other
downstream kinases, including Akt and protein kinase C (PKC)-
, that
mediate translocation of GLUT4. PTP1B is a protein tyrosine
phosphatase (PTPase) that negatively regulates insulin signaling
pathways by dephosphorylating the insulin receptor and IRS-1.
Interestingly, IRS-1 and PTP1B upstream from Akt and PKC-
have
recently been identified as substrates for these downstream kinases,
suggesting that feedback mechanisms exist (9, 33, 38, 39).
Elements downstream from Akt and PKC-
linking insulin signaling
pathways with trafficking machinery for GLUT4 are unknown (34). Thus a complete understanding of mechanisms
regulating the metabolic actions of insulin has remained elusive.
One reason it has been difficult to comprehend metabolic insulin
signaling pathways is that determinants of signal specificity are
poorly understood. Many signaling molecules are shared in common among
pathways initiated by distinct receptors. Moreover, cross talk
and feedback between a multitude of receptor-mediated pathways
generate signaling networks rather than linear pathways. Without
a theoretical framework, it is difficult to understand how complexities
evident from experimental data determine cell behavior. Now that the
human genome has been sequenced, it may be possible to generate a vast
experimental database for understanding cellular signaling. Alfred
Gilman has founded The Alliance for Cellular Signaling
(http://www.cellularsignaling.org/) with the goal of
integrating relevant experimental data (temporal and spatial
relationships of signaling inputs and outputs in a cell) into
interacting theoretical models. This comprehensive approach may enable
a full understanding of the complexities of cell signaling. In this
spirit, we now develop a mathematical model of metabolic insulin
signaling pathways that explicitly represents many known insulin
signaling components. Our goal is to define a comprehensive model that
not only accurately represents known experimental data but will also
serve as a useful tool to generate and test hypotheses. This modeling
approach may lead to novel insights regarding the molecular mechanisms
underlying insulin signal transduction pathways that regulate metabolic
actions of insulin.
 |
MODEL DEVELOPMENT |
We use our previously validated models of insulin receptor
binding kinetics (57), receptor recycling
(36), and GLUT4 translocation (35, 37) as
subsystems in conjunction with a novel mechanistic representation of
postreceptor signaling pathways to generate a complete model with 21 state variables. This complete model is then extended to incorporate
feedback pathways, and consequences of feedback are explored.
Differential equations derived from the structure of the complete model
were solved by use of a fourth order Runge-Kutta numerical integration
routine (42), using the WinPP version of XPPAUT (available
at http://www.math.pitt.edu/~bard/xpp/xpp.html; see
APPENDIX A for complete list of equations, initial conditions, and model parameters; see
http://mrb.niddk.nih.gov/sherman for WinPP source files used
to run simulations). A sufficiently small step size (0.001 min) was
used to ensure accurate numerical integrations for all state variables.
First order kinetics were assumed except where noted.
Complete Model without Feedback
Insulin receptor binding subsystem.
Our model of insulin receptor binding kinetics (57) (Fig.
1A) was extended here to
include additional steps representing insulin receptor
autophosphorylation and dephosphorylation (Fig. 1B). On
binding the first molecule of insulin, the receptor is rapidly
phosphorylated (1), resulting in receptors that may either
bind another molecule of insulin or dissociate from the first molecule
of insulin. Binding of a second molecule of insulin does not affect the
phosphorylation state of the receptor, whereas receptor
dephosphorylation occurs when insulin diffuses off of the receptor,
leaving a free receptor. In addition, protein tyrosine phosphatases
that dephosphorylate the insulin receptor and whose levels can vary
under pathological conditions (15) are explicitly represented as a multiplicative factor ([PTP]) that modulates receptor dephosphorylation rate. The differential equations for this
subsystem are
|
(1)
|
|
(2)
|
|
(3)
|
|
(4)
|
|
(5)
|
Definitions for state variables and rate constants are given in
legend to Fig. 1, A and B. Note that we do not
explicitly include an intermediate state of free receptors that are
still phosphorylated because receptor occupancy and phosphorylation are
tightly coupled, and we assume that there are virtually no receptors in
the unbound phosphorylated state.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Schematic of insulin receptor binding and life cycle
subsystems. A: previously validated model of insulin binding
kinetics (57). x1, Free insulin
concentration (system input); x2, free receptor
concentration; x3, concentration of receptors
with 1 molecule of insulin bound; x4,
concentration of receptors with 2 molecules of insulin bound;
k1 and k 1, association
and dissociation rate constants, respectively, for the first molecule
of insulin to bind the receptor; k2 and
k 2, association and dissociation rate
constants, respectively, for the second molecule of insulin to bind the
receptor. B: receptor binding subsystem extended to include
receptor autophosphorylation and dephosphorylation.
x5, Concentration of once-bound phosphorylated
receptors; x4, redefined as concentration of
twice-bound phosphorylated receptors; k3, rate
constant for receptor autophosphorylation; k 3,
rate constant for receptor dephosphorylation; [PTP], a multiplicative
factor modulating k 3 that represents the
relative activity of protein tyrosine phosphatases (PTPases) in the
cell that dephosphorylate the insulin receptor. C:
previously validated model of insulin receptor recycling
(36). x6, Concentrations of
intracellular receptors; k4, endocytosis rate
constant for free receptors; k 4, exocytosis
rate constant; k4', endocytosis rate constant
for bound receptors; k5, zero order rate
constant for receptor synthesis; k 5, constant
for receptor degradation. D: extension of insulin receptor
binding and recycling subsystems that includes phosphorylated
receptors. x7 and x8,
concentration of twice-bound and once-bound intracellular
phosphorylated receptors, respectively; k 4',
exocytosis rate for twice-bound and once-bound intracellular
phosphorylated receptors; k6, dephosphorylation
rate constant for intracellular receptors that is modulated by the
multiplicative factor [PTP].
|
|
Insulin receptor recycling subsystem.
Our previous model of insulin receptor life cycle explicitly represents
synthesis, degradation, exocytosis, and both basal and ligand-induced
endocytosis of receptors (36) (Fig. 1C). We now
extend this subsystem so that ligand-induced endocytosis is only
applied to phosphorylated cell surface receptors (Fig. 1D).
Both once- and twice-bound phosphorylated receptors are treated identically with respect to internalization. An additional step representing dephosphorylation of internalized phosphorylated receptors
and their incorporation into the intracellular pool is included. State
variables representing free surface insulin receptors
(x2) and phosphorylated surface receptors
(x4 and x5) are shared by
both binding and recycling subsystems. Thus differential equations for
these coupled subsystems (depicted in Fig. 1D) are
|
(6)
|
|
(7)
|
|
(8)
|
|
(9)
|
|
(10)
|
|
(11)
|
|
(12)
|
|
(13)
|
Definitions for additional state variables and rate constants
are given in legend to Fig. 1, C and D.
Postreceptor signaling subsystem.
The postreceptor signaling subsystem developed here (Fig.
2) comprises elements in the metabolic
insulin signaling pathway that are well established (32).
It is assumed that this is a closed subsystem so that synthesis and
degradation of signaling molecules are not explicitly represented. The
concentration of phosphorylated surface insulin receptors is the input
to this subsystem. Activated insulin receptors phosphorylate IRS-1,
which then binds and activates PI 3-kinase. We modeled the dependence of IRS-1 phosphorylation on phosphorylated surface receptors as a
linear function. That is, the rate constant for IRS-1 phosphorylation, k7, is modulated by the fraction of
phosphorylated surface receptors (x4 + x5)/(IRp), where IRp is
the concentration of phosphorylated surface receptors achieved after
maximal insulin stimulation. The association of phosphorylated IRS-1
with PI 3-kinase is assumed to occur with a stoichiometry of 1:1.
Differential equations governing phosphorylation of IRS-1 and
subsequent formation of phosphorylated IRS-1/activated PI 3-kinase
complex are
|
(14)
|
|
(15)
|
|
(16)
|
|
(17)
|
Activated PI 3-kinase converts the substrate
phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] to the
product PI(3,4,5)P3. This is modeled as a linear
function so that k9, the rate constant for
generation of PI(3,4,5)P3, is dependent on
x12, the amount of activated PI 3-kinase
(see APPENDIX B for detailed derivation). 5'-Lipid
phosphatases such as SHIP2 convert PI(3,4,5)P3 to
phosphatidylinositol 3,4-bisphosphate PI(3,4)P2]
(6), whereas 3'-lipid phosphatases such as PTEN convert
PI(3,4,5)P3 to PI(4,5)P2 (45). The
differential equations describing interconversion between these
phosphatidylinositides are
|
(18)
|
|
(19)
|
|
(20)
|
As with [PTP], the lipid phosphatase factors [SHIP] and
[PTEN] correspond to the relative phosphatase activity in the cell and are assigned a value of 1 under normal physiological conditions.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Schematic of postreceptor signaling subsystem.
x9, Concentration of unphosphorylated insulin
receptor substrate (IRS)-1; x10, concentration
of tyrosine-phosphorylated IRS-1; x11,
concentration of free phosphatidylinositol 3-kinase (PI 3-kinase;
PI3-K); x12, concentration of the phosphorylated
IRS-1/activated PI 3-kinase complex; x13,
x14, and x15, percentages
of various phosphoinositol lipids in the cell;
x16 and x17, percentages
of unphosphorylated and phosphorylated Akt in the cell, respectively;
x18 and x19, percentages
of unphosphorylated and phosphorylated protein kinase C (PKC)- in
the cell, respectively. The rate constants k7 to
k12 and k 7 to
k 12 govern the conversion between state
variables as indicated. [PTP] is a multiplicative factor modulating
k 7 that represents the relative activity of
PTPases in the cell that dephosphorylate IRS-1. [PTEN] and [SHIP]
are multiplicative factors modulating k 9 and
k 10, respectively, that represent the relative
activity of these lipid phosphatases in the cell. Arrows with solid
lines indicate first-order reactions. Arrows with dashed lines indicate
reactions where the value of a state variable influences the value of
the rate constant.
|
|
Activation of downstream Ser/Thr kinases Akt and PKC-
is dependent
on levels of PI(3,4,5)P3 (2, 49). In our
model, this is governed by rate constants that interact with the level
of PI(3,4,5)P3 (see APPENDIX B for detailed
derivation). The differential equations describing this are
|
(21)
|
|
(22)
|
|
(23)
|
|
(24)
|
The output of this subsystem is represented as a metabolic
"Effect" due to Akt and PKC-
activity, with 80% of the
metabolic insulin signaling effect attributed to PKC-
and 20% of
the effect attributed to Akt (3, 7, 49)
|
(25)
|
where APequil is the steady-state level of combined
activity for Akt and PKC-
after maximal insulin stimulation
(normalized to 100%). Definitions for additional state variables and
rate constants in the postreceptor signaling subsystem are given in the
legend to Fig. 2.
GLUT4 translocation subsystem.
The final subsystem is our previous model of GLUT4 translocation
(35, 37) (Fig. 3). Under
basal conditions, GLUT4 recycles between an intracellular compartment
and the cell surface. The differential equations for this subsystem are
|
(26)
|
|
(27)
|
Definitions for additional state variables and rate constants in
the GLUT4 translocation subsystem are given in the legend to Fig. 3. On
insulin stimulation, there may be a separate pool of intracellular
GLUT4 recruited to the cell surface (17, 18, 40). To
represent this aspect of GLUT4 trafficking, the insulin-stimulated exocytosis rate (k13') is increased to its
maximum value as a linear function of the metabolic effect produced by
phosphorylated Akt and PKC-
. By assuming that the basal equilibrium
distribution of 4% cell surface GLUT4 and 96% GLUT4 in the
intracellular pool transitions on maximal insulin stimulation to a new
steady state of 40% cell surface GLUT4 and 60% intracellular GLUT4,
the equations governing changes in k13 and
k13' are
|
(28)
|
|
(29)
|
Thus changes in k13' are linearly
dependent on the output of the signaling subsystem (Effect).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 3.
Schematic of GLUT4 translocation subsystem (35, 37).
x20, Percentage of intracellular GLUT4;
x21, percentage of GLUT4 at the cell surface;
k 13, rate constant for GLUT4 internalization;
k13, rate constant for translocation of GLUT4 to
the cell surface under basal conditions; k13',
rate constant for translocation of GLUT4; k14
(zero order) and k 14, rate constants for GLUT4
synthesis and degradation, respectively. The "metabolic Effect"
from postreceptor signaling subsystem increases
k13'.
|
|
For our complete model without feedback, the four subsystems described
above were coupled by shared common elements (Fig. 4) (see APPENDIX B for
derivation of initial conditions, rate constants, and parameters).

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 4.
Complete model of metabolic insulin signaling pathways obtained by
coupling subsystem models for insulin receptor binding, receptor
recycling, postreceptor signaling, and GLUT4
translocation.
|
|
Complete Model with Feedback
Recent evidence suggests that Akt and PKC-
may participate in
positive and negative feedback in metabolic insulin signaling pathways
(9, 33, 38, 39). To investigate potential functional consequences of these feedback pathways, we incorporated both positive
and negative feedback loops into our complete model (Fig. 5). Phosphorylation of PTP1B by Akt
impairs the ability of PTP1B to dephosphorylate insulin receptors and
IRS-1 by 25% (38). Because PTP1B itself negatively
modulates insulin signaling, the downstream negative regulation of an
upstream negative signaling element represents a positive feedback loop
for insulin signaling. We implemented this positive feedback loop by
assuming a linear effect of activated Akt (x17)
to inhibit PTP1B activity with a 25% decrease in [PTP] at maximal
insulin stimulation. Thus [PTP] is multiplied by 1
0.25x17/(100/11) (where 100/11 is the percentage of activated Akt after maximal insulin stimulation and for
x17
400/11; otherwise, [PTP] = 0; see
APPENDIX B for derivation).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 5.
Complete model of metabolic insulin signaling pathways with
feedback. Identical to model shown in Fig. 4 except that new elements
comprising positive and negative feedback pathways are indicated by
dotted lines. PKC- serine phosphorylates IRS-1 to create a negative
feedback pathway, and Akt phosphorylates PTP1B to create a positive
feedback pathway.
|
|
We also incorporated a negative feedback loop in which serine
phosphorylation of IRS-1 by PKC-
impairs formation of the
phosphorylated IRS-1/activated PI 3-kinase complex (39).
To represent this, we assumed that serine phosphorylation of IRS-1 by
activated PKC-
creates an IRS-1 species unable to associate with and
activate PI 3-kinase (represented by the state variable
x10a). The formation of
x10a tends to decrease the level of activated
PI 3-kinase in response to insulin stimulation (when compared with a
system without negative feedback). Additional differential equations
describing interconversion between unphosphorylated IRS-1
(x9) and serine-phosphorylated IRS-1
(x10a) are
|
(30)
|
|
(31)
|
where Eq. 30 is an updated version of Eq. 14, k7' is the rate constant for serine
phosphorylation of IRS-1 by PKC-
, and k
7'
is the rate constant for serine dephosphorylation. We include a
multiplicative factor, [PKC], that modulates
k7' to model the ability of phosphorylated,
activated PKC-
(x19) to generate
serine-phosphorylated IRS-1. [PKC] is defined as a standard Hill
equation that is commonly used to represent enzyme kinetics, where
[PKC] = Vmaxx19(t
)n/[K
+ x19 (t
)n], where Vmax is
maximal velocity and Kd is dissociation
constant. This explicitly incorporates a time lag (
) into
the negative feedback loop. The parameters used in this equation are
listed in APPENDIX A.
 |
RESULTS |
Model Simulations without Feedback
We began evaluation of our complete model without feedback by
generating time courses for all state variables in response to a
maximally stimulating step input of 10
7 M insulin
that was turned off after 15 min (Figs. 6
and 7). Thirty seconds after the
initial insulin stimulation, ~98% of the free insulin receptors
became bound to insulin and underwent autophosphorylation (Fig. 6,
A-C). Phosphorylated once-bound insulin receptors at the cell surface made up ~75% of the surface receptor population, and phosphorylated twice-bound surface receptors comprised ~23% of
the surface receptor population. When insulin was removed after 15 min
of stimulation, the concentration of free insulin receptors returned to
basal levels with a half-time of ~3.5 min. A short transient rise in
the concentration of phosphorylated surface receptors bound to one
molecule of insulin was observed as phosphorylated twice-bound surface
receptors passed through the once-bound state to return to the unbound
free state. As expected, the state variables x6,
x7, and x8, which
represent intracellular insulin receptors, did not change very much
with an acute insulin stimulation (data not shown). These results are
in good agreement with both published experimental data and previous
results from our subsystem models of receptor binding and recycling
(36, 51, 57). In response to the rise in
autophosphorylated surface insulin receptors, unphosphorylated IRS-1
was rapidly converted to tyrosine-phosphorylated IRS-1 (Fig. 6D). Consistent with published experimental data
(29), maximal IRS-1 tyrosine phosphorylation was observed
within 1 min of the initiation of insulin stimulation. On removal of
insulin, IRS-1 underwent dephosphorylation back to basal conditions
with a half-time of ~8 min. This was also consistent with published
experimental data (24).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Model simulations without feedback. Time courses for unbound
receptors (A), once- and twice-bound phosphorylated surface
receptors (B), total phosphorylated surface receptors
(C), and unphosphorylated and tyrosine-phosphorylated IRS-1
(D) after a step input of 10 7 M insulin for 15 min.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 7.
Model simulations without feedback. Time courses for
activated PI 3-kinase (A), levels of phosphatidylinositol
3,4,5-trisphosphate [PI(3,4,5)P3] and
phosphatidylinositol 3,4-bisphosphate PI(3,4)P2]
(B), activated PKC- (C), and cell
surface GLUT4 (D) after a step input of
10 7 M insulin for 15 min.
|
|
Maximal formation of the phosphorylated IRS-1/activated PI 3-kinase
complex in response to 10
7 M insulin occurred within
~1.5 min (Fig. 7A). This is in good agreement with
published data showing that PI3-kinase and tyrosine-phosphorylated IRS-1 molecules associate quickly after insulin stimulation (2, 14). The time course for disappearance of activated PI 3-kinase after the removal of insulin followed the time course for
dephosphorylation of IRS-1. PI 3-kinase activated in response to
insulin stimulation catalyzed the conversion of PI(4,5)P2
to PI(3,4,5)P3, which in turn drove the formation of
PI(3,4)P2 (Fig. 7B). The level of PI(3,4,5)P3 increased from 0.31 to 3.1% of the total lipid
population, and the level of PI(3,4)P2 increased from 0.29 to 2.9% of the total lipid population as it equilibrated with
PI(3,4,5)P3. On removal of insulin, the
phosphatidylinositides returned to basal levels (time to half-maximal
levels was ~11 min). The levels of PI(3,4,5)P3 controlled
the formation of phosphorylated, activated PKC-
(Fig.
7C). Maximal PKC-
activation occurred within 3 min of
insulin stimulation. After insulin was removed, the level of activated
PKC-
declined back to basal levels (time to half-maximal levels was
~11 min). The time course for phosphorylated, activated Akt was
identical to that for PKC-
(data not shown). Insulin-stimulated activation of PKC-
and Akt mediates increased exocytosis of GLUT4 so
that 40% of total cellular GLUT4 was at the cell surface and 60% was
intracellular after maximal insulin stimulation (Fig. 7D).
Our simulations of insulin-stimulated GLUT4 recruitment occurred with a
half-time of ~3 min, matching published experimental results (18, 20). When insulin was removed, surface and
intracellular GLUT4 levels returned to their basal values (time to
half-maximal levels was ~16 min). Thus the overall response of our
complete model without feedback to an acute insulin input is in good
agreement with both a variety of published experimental data and
previously validated subsystem models.
Model Simulations with Feedback
Having developed a plausible mechanistic model of metabolic
insulin signaling pathways related to translocation of GLUT4, we next
explored the effects of including positive and negative feedback loops
to gain additional insight into the complexities of insulin signaling.
Phosphorylation of PTP1B by Akt partially inhibits the ability of PTP1B
to dephosphorylate the insulin receptor and IRS-1 (38). In
addition, PKC-
phosphorylates serine residues on IRS-1 and inhibits
the ability of IRS-1 to bind and activate PI 3-kinase
(39). As described in MODEL DEVELOPMENT, we
incorporated these positive and negative feedback interactions into our
model. As for the model without feedback, we generated time courses for all state variables in response to a maximally stimulating step input
of 10
7 M insulin for 15 min (Figs.
8 and
9). Time courses for the various insulin receptor states in response to insulin stimulation were qualitatively similar to results obtained from our model without feedback (cf. Fig. 6). However, after removal of insulin, the return of
free surface receptors to basal levels and the disappearance of total
phosphorylated surface receptors occurred a little more slowly than in
the model without feedback. These results are consistent with the
presence of a positive feedback loop at the level of the insulin
receptor. With incorporation of negative feedback at the level of
IRS-1, the time course for IRS-1 tyrosine phosphorylation in response
to insulin stimulation is quite different from model simulations
generated without feedback. In response to insulin, the level of
tyrosine-phosphorylated IRS-1 transiently reached a peak of 0.84 pM
within 1.5 min. This was followed by a rapid 60% decrease before a
final equilibration at ~0.30 pM by 11 min (Fig. 8D). Thus
the presence of negative feedback at the level of IRS-1 caused
transient oscillatory behavior and a lower steady-state level for
tyrosine-phosphorylated IRS-1. Levels of serine-phosphorylated IRS-1
first began to rise after 1.5 min of insulin stimulation. Similar to
tyrosine-phosphorylated IRS-1, the concentration of serine-phosphorylated IRS-1 equilibrated at 0.76 pM after 5 min of
insulin stimulation. Less than 10% of the total IRS-1 remained in the
unactivated state after maximal insulin stimulation. Removal of insulin
resulted in conversion of both serine- and tyrosine-phosphorylated IRS-1 back to unphosphorylated IRS-1 (time to return to half-maximal levels was ~17 min).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 8.
Model simulations with feedback. Time courses for unbound receptors
(A), once- and twice-bound phosphorylated surface receptors
(B), total phosphorylated surface receptors (C),
and unphosphorylated, serine-phosphorylated, and
tyrosine-phosphorylated IRS-1 (D) after a step input of
10 7 M insulin for 15 min.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 9.
Model simulations with feedback. Time courses for activated
PI 3-kinase (A), levels of PI(3,4,5)P3 and
PI(3,4)P2 (B), activated PKC- (C),
and cell surface GLUT4 (D) after a step input of
10 7 M insulin for 15 min.
|
|
The transient oscillatory behavior observed for tyrosine-phosphorylated
IRS-1 in response to insulin stimulation was also observed for
activated PI 3-kinase (Fig. 9A). Activated PI 3-kinase transiently peaked at 5.6 fM within 1.8 min. This was followed by a
rapid undershoot and then equilibration at ~1.9 fM by 10 min. On
removal of insulin, the concentration of activated PI 3-kinase
returned to basal levels (time to half-maximal levels was ~17
min). The time courses for PI(3,4,5)P3,
PI(3,4)P2, PKC-
, and Akt displayed a qualitatively
similar dynamic (Fig. 9, B and C). That is,
after 1 min of insulin stimulation, the level of PI(3,4,5)P3 increased from 0.31% of the total lipid
population to a peak of ~6.1% followed by an undershoot before
equilibration at ~2.5%. The level of PI(3,4)P2 increased
from 0.21% to a peak of ~5.6% before equilibrating at a
steady-state level of ~2.4%. On removal of insulin, both
PI(3,4,5)P3 and PI(3,4)P2 returned to their
basal levels (time to half-maximal levels was ~17 min). In response
to insulin, the percentage of activated PKC-
transiently peaked at
~17.1% after ~1.5 min followed by an undershoot and equilibration
at ~7.4% by 11 min. After insulin was removed, the level of
activated PKC-
declined to basal levels with a time to half-maximal
levels of ~17 min. Because we modeled the behavior of Akt identically
to PKC-
, the time course for phosphorylated, activated Akt mirrored
that for PKC-
(data not shown). With respect to translocation of
GLUT4, the overall shapes of the time courses for cell surface GLUT4
with and without feedback were similar. However, with inclusion of
positive and negative feedback loops, described above, the half-time
for translocation of GLUT4 to the cell surface in response to insulin
was slightly shorter than that observed in the model without feedback
(~2.5 min), whereas the time for return to basal levels after insulin
removal was longer (time to half-maximal level was ~18 min). Thus the
inclusion of positive and negative feedback loops into our model of
metabolic insulin signaling generates predictions regarding the
dynamics of various signaling components that may be experimentally testable.
Insulin Dose-Response Characteristics
We generated simulations of insulin dose-response curves to
further explore characteristics of our model with and without feedback.
Step inputs ranging from 10
6 to 10
12 M
insulin for 15 min were used to construct dose-response curves for
maximum levels of bound insulin receptors at the cell surface, total
phosphorylated receptors at the cell surface, activated PI3-kinase, and
cell surface GLUT4 (Fig. 10). Published
experimental data corresponding to each of these elements were then
compared with simulation results. The experimental data used for
comparison were obtained from a series of experiments performed in the
same preparation of rat adipose cells (47). For bound
surface insulin receptors (x3 + x4 + x5), the
dose-response curve generated by our model without feedback had a
half-maximal effective dose (ED50) of 3.5 nM (Fig.
10A). Our model with feedback generated a curve with an
ED50 of 2.9 nM. Both of these simulation results were similar to the experimentally determined ED50 of 7 nM that
was reported by Stagsted et al. (47). With respect to
receptor autophosphorylation, model simulations without feedback
generated a dose-response curve for surface phosphorylated receptors
(x4 + x5) with an
ED50 of 3.5 nM (Fig. 10B). Model simulations
with feedback generated a dose-response curve with an ED50
of 2.9 nM. The experimentally determined ED50 for receptor
autophosphorylation was reported as 5 nM (47). The close
similarity between insulin dose-response curves for receptor binding
and receptor autophosphorylation observed in both our simulations and
the experimental data is consistent with the tight coupling of the
dynamics of these processes.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 10.
Experimentally generated insulin dose-response curves adapted from
Ref. 47 were compared with dose-response curves generated
from our model with and without feedback for bound receptors
(A), phosphorylated receptors at the cell surface
(B), PI 3-kinase activity (C), and glucose
uptake (D; assumed to be directly proportional to GLUT4
levels at the cell surface).
|
|
For activated PI 3-kinase, model simulations without feedback
generated an insulin dose-response curve with an ED50 of
0.83 nM. Model simulations with feedback showed a slightly greater sensitivity with an ED50 of 1.43 nM. These simulation
results seem reasonable, since downstream components should have
greater insulin sensitivity than proximal events if one assumes that
signal amplification occurs for downstream elements. Interestingly, the experimentally determined ED50 for activated PI 3-kinase
reported by Stagsted et al. (47) is 8 nM. With respect to
insulin-stimulated translocation of GLUT4, model simulations without
feedback generated a dose-response curve with an ED50 of
0.53 nM, whereas model simulations with feedback generated a
dose-response curve with a slightly smaller ED50 of 0.19 nM. In rat adipose cells, the ED50 = 0.17 nM for
insulin-stimulated glucose uptake (47). Again, our
simulation results are not only consistent with kinetic expectations
but also closely match experimental results, including observations that maximal glucose uptake occurs with partial insulin receptor occupancy (47). A general result from these model
simulations is that insulin sensitivity increases for components
farther downstream in the signaling pathway. In addition, the presence
of feedback in our model resulted in slightly increased sensitivity for
each signaling component examined compared with simulations without feedback.
Biphasic Activation of PKC-
Biphasic activation of PKC-
in rat adipocytes in response to
insulin stimulation has been previously reported (48, 50). However, the mechanism underlying this dynamic is unknown. To determine
whether the presence of feedback in insulin signaling pathways might
account for this biphasic response, we compared published experimental
data on activation of PKC-
with model simulations in the presence or
absence of feedback. We used a step input of 10
8 M
insulin for 15 min to mimic the experimental conditions reported in
Standaert et al. (48). Intriguingly, the time course for activated PKC-
in response to insulin generated from the simulation with feedback displayed a biphasic dynamic that more closely matched the experimental data, whereas the model without feedback failed to
produce a biphasic response (Fig. 11).
Thus one possible mechanism to generate a biphasic activation of
PKC-
in response to insulin is the presence of feedback pathways.

View larger version (22K):
[in this window]
[in a new window]
|
Fig. 11.
Biphasic activation of PKC- in response to insulin
stimulation. Published data on insulin-stimulated activation of PKC-
(adapted from Ref. 48, Fig. 2A;
) were compared with simulation results from our model
with ( ) and without ( ) feedback using a
step input of 10 8 M insulin for 15 min.
|
|
Effects of Increased Levels of PTPases on Insulin-Stimulated
Translocation of GLUT4
To demonstrate the ability of our model to represent pathological
conditions, we ran model simulations without feedback where we examined
the effects of increased PTPase activity on translocation of GLUT4.
Simulations of the time courses for cell surface GLUT4 were generated
for 15-min insulin step inputs of 10
7, 10
9,
and 10
10 M and [PTP] = 1. These control curves
were then compared with simulations in which [PTP] = 1.5 (mimicking diabetes or obesity). As might be predicted,
increasing [PTP] resulted in a decreased amount of cell surface
GLUT4 at every insulin dose and a more rapid return to the basal
state when insulin is removed (Fig. 12). Moreover, the effect of increased
PTPase activity to reduce cell surface GLUT4 (in terms of percentage)
is more pronounced at lower insulin doses. Thus, at an insulin dose of
10
7 M, increasing [PTP] by 50% causes a 6.5% decrease
in peak insulin-stimulated GLUT4 at the cell surface, whereas at the
10
10 M insulin dose, a 50% increase in [PTP]
results in a 27.9% decrease in peak insulin-stimulated cell
surface GLUT4. These results are consistent with the
amplification properties of this signal transduction system and the
function of PTPases to negatively regulate insulin signaling at the
level of the insulin receptor and IRS-1. Model simulations with
feedback gave qualitatively similar results (data not shown).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 12.
Effects of increasing PTP on time courses for
insulin-stimulated translocation of GLUT4. Simulations for cell surface
GLUT4 in response to a 15-min step input of 10 7 M insulin
(A), 10 9 M insulin (B), and
10 10 M insulin (C) are shown for [PTP] = 1.0 (open symbols) and [PTP] = 1.5 (solid symbols) using our model
without feedback.
|
|
 |
DISCUSSION |
Since the discovery of insulin over 80 years ago, tremendous
progress has been made in elucidating the molecular mechanisms of
insulin action. However, recent investigations of insulin signaling reveal biological complexities that are still not fully understood. For
example, the determinants of specificity for metabolic insulin signaling pathways are largely unknown. Rapid progress in the field of
signal transduction and genomics has inspired the foundation of groups
such as the National Resource for Cell Analysis and Modeling (NRCAM;
pioneers in the Virtual Cell project; see Ref. 41) and The
Alliance for Cellular Signaling. These groups strongly argue that a
theoretical approach with a comprehensive database is absolutely
necessary for a full understanding of cellular signaling behavior.
Model Development
Previous applications of mathematical modeling to insulin action
have focused on limited areas such as receptor binding kinetics and
GLUT4 trafficking (17, 35-37, 43, 44, 57). The
predictive power of these models has been useful for understanding
particular aspects of insulin action. In the present work, we
incorporate some of these models along with a novel current description
of insulin signal transduction elements into a complete model of metabolic insulin signaling pathways. Because some signaling elements represented in the model have just recently been discovered,
biochemical characterization of the kinetics for these elements
remains incomplete. For example, time courses of activation are often
reported with reference to insulin stimulation without
characterization relative to immediate upstream precursors. Moreover,
limitations in experimental approaches preclude the determination of
some time courses with sufficient resolution. Thus we did not
explicitly include an element for PDK-1 between the generation of
PI(3,4,5)P3 and the phosphorylation of PKC-
and Akt
because insufficient kinetic data are available in the literature.
Similarly, elements downstream from PKC-
and Akt that link metabolic
insulin signaling pathways with the machinery for GLUT4 trafficking are
unknown and therefore not explicitly represented.
One potential pitfall in developing such a complicated model is that
the number of arbitrary free parameter choices may decrease the
predictive power of the model. To address this issue, we incorporated previous models as subsystems in our complete model to significantly reduce the number of arbitrary elements. Rate constants and parameters for these subsystems had previously been independently obtained and
validated. The majority of remaining model parameters and rate
constants characterizing newly modeled steps of the metabolic insulin
signaling pathway were based on experimental data in the literature. We
also used boundary value conditions to derive fixed relationships among
various rate constants and model parameters to further decrease the
degrees of freedom in the structure of the model. Finally, as a
simplifying measure, we represented the numerous kinetic reactions in
our model as first-order reactions coupled by shared common elements.
We have attempted to thoroughly validate our complete model by
demonstrating that the behavior of each individual state variable in
response to a step insulin input closely matches experimental data from
a variety of independent sources. As further evidence of the validity
of our complete model, our system as a whole generated properties that
have been observed experimentally, including the presence of "spare
receptors" (e.g., maximal activation of GLUT4 translocation with
submaximal insulin receptor occupancy), signal amplification, and
increased insulin sensitivity for downstream components in the
signaling pathway. Because three of the four model subsystems have
previously been validated and the behavior of the overall model agrees
closely with published experimental data, we conclude that our
postreceptor signaling subsystem is reasonable and robust. Moreover,
the rate constants chosen for the signaling subsystem were based on
data in the literature. Although a more complete exploration of the postreceptor signaling subsystem is of interest, this is beyond the
scope of the current study.
In some cases where mechanisms regulating interactions between
signaling elements are not fully understood, we modeled these interactions as linear relationships. The rate of IRS-1 phosphorylation in response to activated insulin receptors, the rate of
PI(3,4,5)P3 generation in response to activated
PI 3-kinase, the rate of PKC-
and Akt phosphorylation in response
to increased levels of PI(3,4,5)P3, and the rate of
exocytosis for GLUT4 in response to phosphorylated PKC-
and Akt are
all modeled as simple linear functions. In the case of the negative
feedback loop where PKC-
phosphorylates IRS-1 on serine residues, we
modulated the rate constant for serine phosphorylation of IRS-1 using a
standard Hill equation to incorporate a reasonable time lag.
Importantly, we observed a good overall match between experimental data
and model simulations for both insulin dose-response curves and time
courses. Thus our coupling assumptions seem reasonable. Nevertheless,
these points in the model represent areas that could be further refined
in the future when a greater understanding of the molecular mechanisms
involved is achieved. Indeed, by modeling more complicated coupling
mechanisms, specific simulation results may give rise to experimentally
testable predictions. This interplay between theoretical predictions
and experimental results may yield important insights into the
molecular mechanisms of insulin action.
Model Simulations without Feedback
We validated the structure of our complete model by comparing
published experimental data with model simulations in response to an
acute insulin stimulus. In our model without feedback, the dynamics of
insulin-stimulated phosphorylation of IRS-1, activation of
PI 3-kinase, production of PI(3,4,5)P3 and
PI(3,4)P2, and phosphorylation of Akt and PKC-
all fit
well with published experimental data (2, 29, 46, 48, 55).
On removal of insulin, the dynamics of the return to basal states in
our simulations showed a time to half-maximal levels of ~8 min for
phosphorylated IRS-1 and activated PI 3-kinase and ~11 min for
PI(3,4,5)P3, phosphorylated Akt, and phosphorylated
PKC-
. Because minimal kinetic data exist regarding the return to
basal levels after removal of insulin, these simulation results
represent predictions of our model. Finally, as expected, time courses
for insulin receptor binding and GLUT4 translocation also matched
experimental data when these subsystems were placed into the context of
the overall model.
In our simulations we observed a time lag between the insulin input and
subsequent steps in insulin signaling that increased as the signal
propagated downstream. This lag was present for simulations of both
insulin stimulation and removal. Because the kinetics governing most
state variables were modeled as first-order events, recovery to basal
conditions of each component would be expected to appear as a
concave-up, exponential decay curve. Interestingly, in our simulations
of insulin removal (after 15-min insulin stimulation), we observed the
presence of a concave-down region immediately before the concave-up
exponential decay that became more pronounced for distal components and
is clearly evident in the simulations of GLUT4 translocation (Fig.
7D). This qualitative behavior is consistent with the
presence of a signaling cascade that controls insulin-stimulated
translocation of GLUT4 and has been observed experimentally in rat
adipose cells (20).
To further validate our complete model without feedback, we compared
published experimental data with simulations of insulin dose-response
curves for key state variables (Fig. 10). The usefulness of these
comparisons was substantially strengthened by the fact that data on
insulin receptor binding, receptor autophosphorylation, PI 3-kinase
activation, and glucose transport were obtained from a single
experimental preparation of rat adipose cells (47). Qualitatively, the sigmoidal shape of dose-response curves generated by
our model simulations (when plotted as a semi-log graph) is consistent
with the hyperbolic response characteristic of most receptor-mediated
biological events. In addition, we observed increased insulin
sensitivity for downstream components of the insulin signaling pathway.
That is, ED50 = 3.5 nM for receptor binding,
ED50 = 3.5 nM for receptor autophosphorylation,
ED50 = 0.83 nM for PI 3-kinase activation, and
ED50 = 0.53 nM for GLUT4 translocation. This increased
sensitivity of downstream components, consistent with the presence of a
signal amplification cascade, is a well-described characteristic for
biological actions of insulin. For example, only a fraction of insulin
receptors need to be occupied by insulin for maximal glucose uptake to
occur in adipose cells (20, 47). Stagsted et al.
(47) reported an ED50 of 8 nM for
insulin-stimulated PI 3-kinase activation. However, close inspection
of their data suggests that the actual value may be closer to 4 nM.
Nevertheless, this ED50 is still somewhat larger than the
ED50 of 0.83 nM derived from our simulations. However, the
measurement of PI 3-kinase activity in anti-phosphotyrosine immunoprecipitates derived from whole cell lysates is difficult to
perform in a quantitative manner. Thus it is possible that the small
discrepancy between our simulation results and experimental data with
respect to activation of PI3-kinase may be explained, in part, by
imprecision introduced by experimental variability. Of note, the shape
and ED50 of insulin dose-response curves for insulin
receptor binding, receptor autophosphorylation, and GLUT4 translocation
almost exactly match the corresponding experimentally determined
dose-response curves (Fig. 10). Thus the insulin sensitivity of key
components of our model is realistic. Moreover, given the fact that our
model structure, rate constants, and parameters were derived from a
large mixture of many different experimental systems, this remarkable
fit to experimental data from a single system across several key state
variables suggests that the overall structure of our model is quite robust.
Model Simulations with Feedback
To further explore the complexities of insulin signaling, we
simultaneously modeled positive and negative feedback loops based on
mechanisms proposed in the literature (9, 33, 38, 39). We
incorporated a positive feedback loop into our model by having Akt
phosphorylate PTP1B and impair its ability to dephosphorylate the
insulin receptor and IRS-1 (38). The slight increase in insulin sensitivity for insulin binding and receptor
autosphosphorylation observed in our model with feedback was an
expected result of positive feedback at the level of the insulin
receptor. That is, decreased activity of PTPases against phosphorylated
insulin receptors results in subtle shifts in the equilibrium states
for the various receptor state variables. Similarly, we observed
slightly decreased sensitivity for the activated PI 3-kinase
dose-response curve derived from our model with feedback. This is the
result of positive feedback with Akt phosphorylating PTP1B and
inhibiting tyrosine dephosphorylation of IRS-1. In addition, the
lower equilibrium level of PI 3-kinase after maximal insulin
stimulation (which defines the parameter PI3K) also contributes to a
shift in insulin sensitivity at the level of PI 3-kinase.
Dose-response curves for translocation of surface GLUT4 derived from
the model with feedback demonstrated greater insulin sensitivity than
simulations without feedback. This was due to the combined effects of
increased sensitivity of proximal signaling elements. Remarkably, the
experimental data for insulin-stimulated glucose uptake reported by
Stagsted et al. (47) indicated an ED50 of 1.7 nM that almost exactly matched the ED50 of 1.9 nM for cell
surface GLUT4 that we calculated from our model with feedback. In
addition to slightly increased insulin sensitivity, the half-times for
return to basal levels of all signaling elements were longer in our
simulations with feedback. These results are consistent with
experimental observations suggesting that positive feedback at the
level of the insulin receptor and IRS-1 slows the return of activated
signaling elements to basal levels (38).
We incorporated a negative feedback loop into our model by modeling the
ability of PKC-
to phosphorylate IRS-1 on serine residues and impair
its ability to bind and activate PI 3-kinase (39). Time
courses for insulin receptor binding and phosphorylation generated by
models with and without feedback were similar. However, the overall
dynamics of postreceptor signaling elements in our model were quite
different with inclusion of feedback. In response to insulin
stimulation, we observed a transient damped oscillatory behavior before
equilibrium was reached in all elements of the postreceptor signaling
subsystem. This oscillatory behavior was a direct result of negative
feedback by PKC-
. Immediately after insulin stimulation, effects of
PKC-
on upstream components are not apparent because of the time lag